{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:58:33Z","timestamp":1772006313720,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11748-019-01131-5","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T08:05:12Z","timestamp":1556784312000},"page":"1007-1013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of postoperative atrial fibrillation in transdermal \u03b2-blocker patch users is lower than that in oral \u03b2-blocker users after cardiac and\/or thoracic aortic surgery"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8806-5110","authenticated-orcid":false,"given":"Homare","family":"Okamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1253\/circj.CJ-12-0142","volume":"76","author":"M Akaishi","year":"2012","unstructured":"Akaishi M. Intravenous infusion of ultra-short-acting \u03b2-blocker for postoperative atrial fibrillation is the one of choice. Circ J. 2012;76:1083\u20134.","journal-title":"Circ J"},{"key":"1131_CR2","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1253\/circj.CJ-13-0273","volume":"77","author":"SK Chua","year":"2013","unstructured":"Chua SK, Shyu KG, Lu MJ, Hung HF, Cheng JJ, Lee SH, et al. Association between renal function, diastolic dysfunction, and postoperative atrial fibrillation following cardiac surgery. Circ J. 2013;77:2303\u201310.","journal-title":"Circ J"},{"key":"1131_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","volume":"94","author":"SF Aranki","year":"1996","unstructured":"Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, Vander Vilet M, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;94:390\u20137.","journal-title":"Circulation."},{"key":"1131_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11748-017-0848-z","volume":"66","author":"A Saito","year":"2018","unstructured":"Saito A, Hirahara N, Motomura N, Miyata H, Takamoto S. Current status of cardiovascular surgery in Japan, 2013 and 2014: a report based on the Japan Cardiovascular Surgery database 3. Coronary artery bypass surgery. Gen Thorac Cardiovasc Surg. 2018;66:8\u201312.","journal-title":"Gen Thorac Cardiovasc Surg."},{"key":"1131_CR5","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association TaskForce on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071\u2013104.","journal-title":"Circulation"},{"key":"1131_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","volume":"53","author":"M Sousa-Uva","year":"2018","unstructured":"Sousa-Uva M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2018;53:5\u201333.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1131_CR7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1253\/circj.CJ-66-0092","volume":"78","author":"JCS Joint Working Group","year":"2014","unstructured":"JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation. Circ J. 2014;78:1997\u20132021.","journal-title":"Circ J"},{"key":"1131_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijcard.2015.06.112","volume":"198","author":"T Hara","year":"2015","unstructured":"Hara T, Yagi S, Akaike M, Sata M. Transdermal patch of bisoprolol for the treatment of hypertension complicated with aortic dissection. Int J Cardiol. 2015;198:220\u20131.","journal-title":"Int J Cardiol"},{"key":"1131_CR9","doi-asserted-by":"publisher","first-page":"e12325","DOI":"10.1111\/1755-5922.12325","volume":"36","author":"A Sairaku","year":"2018","unstructured":"Sairaku A, Nakano Y, Shiode N, Suenari K, Oda N, Ono K, et al. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet. Cardiovasc Ther. 2018;36:e12325.","journal-title":"Cardiovasc Ther."},{"key":"1131_CR10","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2169\/internalmedicine.8846-17","volume":"56","author":"S Godo","year":"2017","unstructured":"Godo S, Kawazoe Y, Ozaki H, Fujita M, Kudo D, Nomura R, et al. Switching therapy from intravenous landiolol to transdermal bisoprolol in a patient with thyroid storm complicated by decompensated heart failure and gastrointestinal dysfunction. Intern Med. 2017;56:2603\u20139.","journal-title":"Intern Med"},{"key":"1131_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jch.12208","volume":"11","author":"H Matsuoka","year":"2013","unstructured":"Matsuoka H, Kuwajima I, Shimada K, Mitamura H, Saruta T. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study. J Clin Hyopertens (Greenwich). 2013;11:806\u201314.","journal-title":"J Clin Hyopertens (Greenwich)."},{"key":"1131_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1253\/circj.CJ-15-0796","volume":"80","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Katayama K, Watanabe M, Kodama H, Taguchi T, Kurosaki T, et al. Preoperative tissue doppler imaging-derived atrial conduction time predicts postoperative atrial fibrillation in patients undergoing mitral valve surgery for mitral valve regurgitation. Circ J. 2016;80:101\u20139.","journal-title":"Circ J"},{"key":"1131_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/eurheartj\/ehn609","volume":"30","author":"D Kaireviciute","year":"2009","unstructured":"Kaireviciute D, Aidietis A, Lip GY. Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. Eur Heart J. 2009;30:410\u201325.","journal-title":"Eur Heart J"},{"key":"1131_CR14","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.jtcvs.2007.08.032","volume":"134","author":"M Banach","year":"2007","unstructured":"Banach M, Goch A, Misztal M, Rysz J, Jaszewski R, Goch JH. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2007;134:1569\u201376.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1131_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11748-016-0738-9","volume":"65","author":"J Yokota","year":"2017","unstructured":"Yokota J, Nishi H, Sekiya N, Yamada M, Takahashi T. Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous \u03b2-blocker. Gen Thorac Cardiovasc Surg. 2017;65:194\u20139.","journal-title":"Gen Thorac Cardiovasc Surg."},{"key":"1131_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1023\/A:1027467617722","volume":"7","author":"PB Maniar","year":"2003","unstructured":"Maniar PB, Balcetyte-Harris N, Tamis JE, Steinberg JS. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev. 2003;7:158\u201361.","journal-title":"Card Electrophysiol Rev."},{"key":"1131_CR17","first-page":"111","volume":"8","author":"R Jalalian","year":"2014","unstructured":"Jalalian R, Ghafari R, Ghazanfari P. Comparing the therapeutic effects of carvedilol and metoprolol on prevention of atrial fibrillation after coronary artery bypass surgery, a double-blind study. Int Cardiovasc Res J. 2014;8:111\u20135.","journal-title":"Int Cardiovasc Res J."},{"key":"1131_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.amjcard.2013.10.020","volume":"113","author":"JJ DiNicolantonio","year":"2014","unstructured":"DiNicolantonio JJ, Beavers CJ, Menezes AR, Lavie CJ, O\u2019Keefe JH, Meier P, et al. Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2014;113:565\u20139.","journal-title":"Am J Cardiol"},{"key":"1131_CR19","first-page":"e652","volume":"124","author":"LD Hillis","year":"2011","unstructured":"Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e652\u2013735.","journal-title":"Circulation"},{"key":"1131_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1253\/circj.CJ-11-1332","volume":"76","author":"A Sakamoto","year":"2012","unstructured":"Sakamoto A, Kitakaze M, Takamoto S, Namiki A, Kasanuki H, Hosoda S, JL-KNIGHT study group. Landiolol, an ultra-short-acting \u03b21-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT Study). Circ J. 2012;76:1097\u2013101.","journal-title":"Circ J."},{"key":"1131_CR21","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jtcvs.2010.10.045","volume":"141","author":"A Sezai","year":"2011","unstructured":"Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011;141:1478\u201387.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1131_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jtcvs.2015.07.003","volume":"150","author":"A Sezai","year":"2015","unstructured":"Sezai A, Osaka S, Yaoita H, Ishii Y, Arimoto M, Hata H, et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: prevention of atrial fibrillation after cardiac surgery with landiolol hydrochloride for left ventricular dysfunction (PLATON) trial. J Thorac Cardiovasc Surg. 2015;150:957\u201364.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1131_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1253\/circj.CJ-17-0532","volume":"82","author":"S Momomura","year":"2018","unstructured":"Momomura S, Saito Y, Yasumura Y, Yamamoto K, Sakata Y, Daimon M, et al. Efficacy and safety of switching from oral bisoprolol to transdermal patch in Japanese patients with chronic heart failure. Circ J. 2018;82:141\u20137.","journal-title":"Circ J"},{"key":"1131_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/bcpt.12818","volume":"121","author":"S Drago","year":"2017","unstructured":"Drago S, Imboden R, Schlatter O, Buylaert M, Kr\u00e4henb\u00fchl S, Drewe J. Pharmacokinetics of transdermal etofenamate and diclofenac in healthy volunteers. Basic Clin Pharmacol Toxicol. 2017;121:423\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1131_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1378\/chest.108.3.718","volume":"108","author":"DG Sinclair","year":"1995","unstructured":"Sinclair DG, Haslam PL, Quinlan GJ, Pepper JR, Evans TW. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest. 1995;108:718\u201324.","journal-title":"Chest"},{"key":"1131_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0003-4975(99)01408-3","volume":"69","author":"M Tokufuji","year":"2000","unstructured":"Tokufuji M, Stahl GL, Metais C, Tomita M, Agah A, Bianchi C, et al. Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg. 2000;69:799\u2013807.","journal-title":"Ann Thorac Surg"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-019-01131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-019-01131-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-019-01131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:54:47Z","timestamp":1744163687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-019-01131-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1007\/s11748-019-01131-5","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"value":"1863-6705","type":"print"},{"value":"1863-6713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}